MARDENTAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,709,494 | 3,110,285 | 2,921,397 | 3,442,048 | 3,847,968 | 3,840,631 | 6,553,608 | 4,019,741 |
| Profit before tax | 172,685 | 168,737 | 228,177 | 299,390 | 242,890 | 121,290 | 462,264 | 155,936 |
| Net profit | 144,298 | 144,770 | 192,469 | 253,311 | 204,934 | 99,208 | 389,989 | 129,314 |
| Equity | 1,362,381 | 1,427,150 | 1,579,619 | 1,787,930 | 1,957,570 | 1,996,778 | 2,286,767 | 2,236,081 |
| Liabilities | 725,593 | 611,853 | 515,024 | 550,513 | 998,501 | 957,194 | 2,255,690 | 1,553,216 |
| Non-current assets | 79,738 | 80,653 | 69,800 | 46,937 | 949,815 | 851,077 | 814,405 | 782,439 |
| Current assets | 1,999,951 | 1,953,803 | 2,021,768 | 2,288,657 | 2,003,427 | 2,097,607 | 3,721,043 | 2,969,741 |
| Total assets | 2,079,689 | 2,034,456 | 2,091,568 | 2,335,594 | 2,953,242 | 2,948,684 | 4,535,448 | 3,752,180 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 698,516 | 786,366 | 831,800 |
| Social insurance contributions | - | - | - | - | - | 95,600 | 112,101 | 111,134 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -23.2% | +14.8% | -6.1% | +17.8% | +11.8% | -0.2% | +70.6% | -38.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.9% | 7.1% | 9.2% | 10.8% | 6.9% | 3.4% | 8.6% | 3.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.6% | 10.1% | 12.2% | 14.2% | 10.5% | 5.0% | 17.1% | 5.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.3% | 4.7% | 6.6% | 7.4% | 5.3% | 2.6% | 6.0% | 3.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 6.4% | 5.4% | 7.8% | 8.7% | 6.3% | 3.2% | 7.1% | 3.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.4 | 0.3 | 0.3 | 0.5 | 0.5 | 1.0 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 205,784 | 213,277 | 213,760 | 237,383 | 246,929 | 241,296 | 439,347 | 283,746 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MARDENTAS - Social security debts
The company had no debts to Sodra
MARDENTAS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MARDENTAS, UAB (code 225863550) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €4.02M and net profit of €129.3K, with a profit margin of 3.2%. Performance softened compared with 2024, when revenue reached €6.55M and net profit €390.0K, but it remained above 2023 levels, when revenue was €3.84M and net profit €99.2K. Over the two-year period from 2023 to 2025, revenue increased by 4.7%, reflecting overall growth despite the latest-year decline. As of 2025, total assets stood at €3.75M, equity at €2.24M and liabilities at €1.55M. The equity ratio was 59.6%, debt-to-equity was 0.69, ROE was 5.8% and ROA was 3.5%. Asset turnover was 1.07x, indicating efficient use of the asset base. Revenue per employee was €287.1K and profit per employee was €9.2K, pointing to solid productivity.